Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

NeuroSense Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:NRSN | Benzinga

Q: What sector and industry does NeuroSense Therapeutics (NRSN) operate in?

NeuroSense Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Explore NeuroSense Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NRSN.

Open	$1.40
Close	$1.52
Volume / Avg.	304.02K / 172.53K
Day Range	$1.39 - $1.57
52 Wk Range	0.51 - 1.63
Market Cap	$37.17M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	71
Short Interest	0.83%
Days to Cover	1.87

Recent News

Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights

NeuroSense expands PrimeC production, partners with a contract organization, and targets early Canadian entry amid a $100–150 million forecast and analyst Buy rating.

Vandana Singh

This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday

Avi Kapoor

EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission

NeuroSense Therapeutics schedules an FDA Type C meeting on Nov. 6 to finalize its Phase 3 trial design for PrimeC, a potential ALS treatment.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.40
Close	$1.52
Volume / Avg.	304.02K / 172.53K
Day Range	$1.39 - $1.57
52 Wk Range	0.51 - 1.63
Market Cap	$37.17M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	71
Short Interest	0.83%
Days to Cover	1.87

About

Sector

Healthcare

Industry

N/A

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and dev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NeuroSense Therapeutics (NRSN) stock?

You can purchase shares of NeuroSense Therapeutics (NASDAQ:NRSN) through any online brokerage.

View our list of the best stock brokerages

Who are NeuroSense Therapeutics (NRSN) competitors?

There are no as such competitors for NeuroSense Therapeutics.

What is the forecast, or price target, for NeuroSense Therapeutics (NRSN) stock?

NeuroSense Therapeutics has a consensus price target of $10.75.

What is the current price for NeuroSense Therapeutics (NRSN)?

The stock price for NeuroSense Therapeutics (NASDAQ: NRSN) is $1.5494 last updated May 23, 2025 at 7:51 PM EDT.

Does NeuroSense Therapeutics (NRSN) pay a dividend?

There are no upcoming dividends for NeuroSense Therapeutics.

When is NeuroSense Therapeutics (NASDAQ:NRSN) reporting earnings?

NeuroSense Therapeutics’s Q1 earnings are confirmed for Monday, June 23, 2025.

Is NeuroSense Therapeutics (NRSN) going to split?

There is no upcoming split for NeuroSense Therapeutics.

What sector and industry does NeuroSense Therapeutics (NRSN) operate in?

NeuroSense Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

NeuroSense Therapeutics Stock Price, Quotes and Forecasts

NeuroSense Therapeutics (NRSN) Forecast